308-nm excimer laser dose titration for vitiligo
Excimer laser is mainly used for
localized vitiligo. It is usually administered
2-3 times weekly, with at least 24 hours between sessions. Fitzpatrick’s notes that response depends more on the
total number of treatments than frequency, although 3 weekly sessions may produce earlier repigmentation. Face, neck, and trunk generally respond better than acral sites.
Fitzpatrick’s summary
Practical evidence-based protocol
| Step | Suggested approach |
|---|
| Before starting | Document lesion photographs and perform a 308-nm MED test where feasible, especially in darker phototypes and on site-specific lesions. |
| Starting dose, MED-based | Start at approximately 70% of the 308-nm MED, or 50 mJ/cm² below the lesional MED. |
| Starting dose, fixed-dose alternative | 100-150 mJ/cm² is a conservative and commonly reported start. A fixed 150 mJ/cm² is used in an Indian review protocol. Some studies begin at 200 mJ/cm², but this is less conservative, particularly on the face. |
| Increment if no erythema at 24 h | Increase 10-15% each session. Published excimer protocols range from 10-25%, occasionally up to 30%, but 10-15% is a sensible routine increment. |
| Faint, asymptomatic erythema lasting <24 h | Continue the same dose, or use a smaller increment of about 5-10%. |
| Symptomatic erythema, erythema lasting >24-48 h, edema, tenderness, or blister | Withhold treatment until resolved. Resume at the last well-tolerated dose or reduce by about 10-25%, depending on severity. Do not escalate through phototoxicity. |
| Course assessment | Treat 2-3 times weekly and reassess after about 24-36 sessions. Many protocols allow up to 48-60 sessions before considering a lesion nonresponsive. |
A clinical trial of localized vitiligo used
100 mJ/cm² initially, with 10-25% increments, twice weekly for up to 60 treatments.
Taneja et al., 2003, PMID: 12890118 A randomized frequency study used an initial exposure
50 mJ/cm² below the 308-nm MED in vitiligo skin, then adjusted each treatment based on erythema.
Hofer et al., 2005, PMID: 15888156
Maximum dose: what to use in Indian patients?
Practical ceiling
For routine 308-nm excimer laser treatment in Indian patients, a reasonable working ceiling is:
- Face, neck, and other sensitive sites: 1,000 mJ/cm² (1 J/cm²)
- Trunk and limbs: 3,000 mJ/cm² (3 J/cm²)
This 150 mJ/cm² start, 15% escalation, and upper limit of
1 J/cm² on the face and 3 J/cm² on the body is stated in an Indian dermatology review of UV therapy for vitiligo.
IJDVL dosing review
Important qualification
There is no validated, India-specific universal maximum dose for 308-nm excimer laser based solely on Fitzpatrick skin type or ethnicity. Dose tolerance varies by:
- anatomic site, especially low facial and high acral tolerance variability
- prior UV exposure and tanning
- active inflammation or friction
- concurrent topical agents
- individual MED and prior phototoxic reactions
- device calibration and spot geometry
An Indian study of
targeted 305-nm UVB lamp therapy, not 308-nm excimer laser, found highly variable MEDs among phototypes IV-VI:
200-1500 mJ/cm², median
600 mJ/cm². This supports individual MED-based dosing but should
not be treated as a direct excimer-laser maximum-dose table because the wavelength and device differ.
Indian MED study
What not to interpret as a routine limit
Older excimer series have reported doses reaching 6,000 mJ/cm², especially in resistant sites. That is a reported study exposure, not a recommended maximum allowance for routine practice. Escalating to high doses, particularly on the face, solely because the patient has darker skin is not evidence-based.
A simple clinic-ready regimen
For a patient with localized non-acral vitiligo:
- MED test preferred, especially in Indian phototypes IV-VI.
- If MED unavailable, start:
- Face: 100-150 mJ/cm²
- Trunk/limbs: 150-200 mJ/cm², cautiously
- Increase by 10-15% per session if there is no clinically relevant erythema at the next visit.
- Maintain the previous dose if mild transient erythema occurs.
- Stop temporarily for painful erythema or blistering; restart at the prior tolerated dose or 10-25% lower.
- Avoid routinely exceeding:
- 1,000 mJ/cm² face
- 3,000 mJ/cm² trunk/limbs
- For hands, feet, elbows, knees, and other acral/bony sites, use an MED-guided rather than an automatic high-dose strategy. These sites often respond poorly despite higher tolerable doses.
Recent systematic reviews support excimer light as an effective treatment, particularly in combination regimens, but do
not establish a superior universal titration schedule or a higher dose ceiling for Indian skin:
Liu et al., 2026, systematic review and network meta-analysis, PMID: 41564112;
Li et al., 2024, systematic review, PMID: 38230424.
This should be used as a dermatologist-supervised phototherapy protocol, with eye protection and strict avoidance of treating photosensitive, infected, or blistered skin.